小肠细菌过度生长:病理生理学及其对定义和管理的启示
本文综述小肠细菌过度生长(SIBO)概念的起源与演变:其最初在吸收不良背景下提出,诊断方法从小肠培养发展到呼气试验及不依赖培养的微生物分析;呼气试验的推广扩大了诊断范围,但其特异性问题引发争议,尤其在肠易激综合征中的作用缺乏病理生理学依据,期待现代分子微生物学提供客观诊断基础。
要点
- SIBO概念源于存在危险因素患者中结肠菌群定植小肠所致的吸收不良。
- 诊断方法从小肠培养演变到呼气试验及不依赖培养的微生物分析。
- 呼气试验特异性问题使SIBO在扩大临床场景中的作用受到质疑。
核心结论
- SIBO作为吸收不良/消化不良的病因具有病理生理学合理性,但其在肠易激综合征等扩大临床场景中的作用缺乏相应依据。
- 期待将不断扩展的现代分子微生物学应用于健康与疾病状态下的人类小肠微生物组,最终解决这一僵局并为SIBO诊断提供客观基础。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- SIBO概念在有明显危险因素的患者中提出,这些患者小肠被潜在有害的结肠微生物群定植,导致可解释的临床体征、症状和实验室异常。
- 诊断检测从小肠培养演变到呼气试验,再到下一代不依赖培养的微生物分析。
- 呼气试验的出现和易获得性使SIBO诊断率及相关的胃肠和非胃肠临床场景范围急剧扩大。
- 呼气试验的特异性问题使对其解读变得模糊,并引发对SIBO在扩大临床场景中作用的质疑。
- 支持SIBO作为消化不良/吸收不良病因的病理生理学合理性,在其据称的肠易激综合征作用方面是缺乏的。
临床怎么用
- 原文未据此给出推荐。
局限性
- 呼气试验的特异性问题使对其解读变得模糊,并引发对SIBO在扩大临床场景中作用的质疑。
- 支持SIBO作为消化不良/吸收不良病因的病理生理学合理性,在其据称的肠易激综合征作用方面是缺乏的。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The concept of small intestinal bacterial overgrowth (SIBO) arose in the context of maldigestion and malabsorption among patients with obvious risk factors that permitted the small bowel to be colonized by potentially injurious colonic microbiota. Such colonization resulted in clinical signs, symptoms, and laboratory abnormalities that were explicable within a coherent pathophysiological framework. Coincident with advances in medical science, diagnostic testing evolved from small bowel culture to breath tests and on to next-generation, culture-independent microbial analytics. The advent and ready availability of breath tests generated a dramatic expansion in both the rate of diagnosis of SIBO and the range of associated gastrointestinal and nongastrointestinal clinical scenarios. However, issues with the specificity of these same breath tests have clouded their interpretation and aroused some skepticism regarding the role of SIBO in this expanded clinical repertoire. Furthermore, the pathophysiological plausibility that underpins SIBO as a cause of maldigestion/malabsorption is lacking in regard to its purported role in irritable bowel syndrome, for example. One hopes that the application of an ever-expanding armamentarium of modern molecular microbiology to the human small intestinal microbiome in both health and disease will ultimately resolve this impasse and provide an objective basis for the diagnosis of SIBO.
引用
- Bushyhead D, Quigley EMM. Small Intestinal Bacterial Overgrowth-Pathophysiology and Its Implications for Definition and Management. Gastroenterology. 2022. PMID: 35398346. doi:10.1053/j.gastro.2022.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。